Astrana Health, Inc. (NASDAQ:ASTH) Receives $49.43 Consensus Target Price from Analysts

Shares of Astrana Health, Inc. (NASDAQ:ASTH) have been given an average recommendation of “Moderate Buy” by the nine ratings firms that are currently covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price objective among analysts that have covered the stock in the last year is $49.4286.

A number of research firms recently weighed in on ASTH. Weiss Ratings upgraded Astrana Health from a “hold (c-)” rating to a “hold (c)” rating in a research note on Monday, June 1st. Robert W. Baird set a $45.00 price objective on Astrana Health in a research report on Friday, May 8th. Wall Street Zen downgraded Astrana Health from a “buy” rating to a “hold” rating in a report on Sunday, August 16th. TD Cowen boosted their target price on shares of Astrana Health from $45.00 to $50.00 and gave the stock a “buy” rating in a research report on Tuesday, July 14th. Finally, BTIG Research upped their price target on shares of Astrana Health from $50.00 to $65.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th.

Astrana Health Trading Down 1.3%

NASDAQ ASTH opened at $37.61 on Wednesday. The company has a quick ratio of 1.23, a current ratio of 1.23 and a debt-to-equity ratio of 1.05. The stock has a market capitalization of $2.10 billion, a P/E ratio of 45.87 and a beta of 0.87. Astrana Health has a 52-week low of $18.08 and a 52-week high of $51.60. The firm has a 50-day moving average price of $41.37 and a 200 day moving average price of $33.70.

Astrana Health (NASDAQ:ASTH) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.80 earnings per share for the quarter, beating analysts’ consensus estimates of $0.34 by $0.46. Astrana Health had a return on equity of 10.30% and a net margin of 1.05%.The company had revenue of $972.52 million for the quarter, compared to analyst estimates of $985.62 million. During the same quarter in the previous year, the company earned $0.19 EPS. The firm’s revenue for the quarter was up 48.5% compared to the same quarter last year. Equities research analysts expect that Astrana Health will post 1.31 EPS for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in ASTH. Royal Bank of Canada increased its holdings in Astrana Health by 6.5% in the first quarter. Royal Bank of Canada now owns 278,619 shares of the company’s stock valued at $8,640,000 after buying an additional 17,028 shares in the last quarter. AQR Capital Management LLC acquired a new stake in shares of Astrana Health in the 1st quarter worth approximately $933,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in shares of Astrana Health by 5.2% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,768 shares of the company’s stock worth $799,000 after acquiring an additional 1,263 shares during the period. Jones Financial Companies Lllp increased its stake in Astrana Health by 4,365.2% in the 1st quarter. Jones Financial Companies Lllp now owns 11,163 shares of the company’s stock valued at $346,000 after purchasing an additional 10,913 shares in the last quarter. Finally, Intech Investment Management LLC increased its stake in Astrana Health by 5.8% in the 1st quarter. Intech Investment Management LLC now owns 44,586 shares of the company’s stock valued at $1,383,000 after purchasing an additional 2,462 shares in the last quarter. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.